Skin Allergy: Atopic Dermatitis

e Multi-Modal Immune Pathogenesis of Atopic Eczema

Atopic eczema (AE) is one of the most common inflammatory diseases, often constituting a lifelong burden for afflicted individuals. Recent findings have provided new insights into the pathogenesis of AE,…

Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?

Atopic dermatitis (AD) is a paradigmatic chronic…

Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate

Treatment of moderate to severe atopic dermatitis (AD) is often inadequate.

Topical Tofacitinib Hits Marks in Atopic Dermatitis

Key clinical point: Topical tofacitinib, a Janus kinase…

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Original Article from The New England Journal of Medicine — Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Dupixent: Injection for Eczema Wins FDA Nod

Approved for patients not responding to or unable to use topical agents